Monroe Capital Supports Vivo Capital’s Acquisition of Serán Bioscience
Monroe Capital acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of Serán Bioscience by private equity sponsor Vivo Capital.
January 8, 2021
Monroe Capital | Serán Bioscience | Vivo Capital
Phil Neuffer